• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
GENERAL PHARMACOLOGY (absorption)
GENERAL PHARMACOLOGY (absorption)

... No complete absorption - Destruction by pH and enzymes - GIT irritation - Food - Drug interactions -Drug-Drug interactions - First pass effect - (low bioavailability). ...
Nitro drugs and the trypanosomatids
Nitro drugs and the trypanosomatids

... Eflornithine inhibits trypanothione biosynthesis – key in the parasite’s defence against oxidant stress ...
25/50 Percent Standalone Drug Plan with Minimum and
25/50 Percent Standalone Drug Plan with Minimum and

... Your copayment will never exceed the maximum copayment listed. In all cases, your copayments are applied to an annual out-of-pocket limit of $2,500. (This limit is separate from the medical plan’s out-ofpocket limit.) Be sure to have your prescriptions filled at a participating pharmacy (see the Net ...
investigational drug services in the hospital
investigational drug services in the hospital

... Objectives of clinical trial should be explained, including risks and benefits, and any alternative therapies available. Outlines the responsibility of the investigator to keep the subject informed about additional information that becomes available as the study progresses ...
Powerpoint Drugs - North Allegheny School District
Powerpoint Drugs - North Allegheny School District

... • ___________ (angel dust) is a synthetically prepared drug – considered to be one of the most dangerous of all drugs. Time seems to pass slowly, body movements slow down, coordination impaired, dulls the sensations of touch and pain. Many PCP users are brought to the emergency room because of its d ...
FROM THE BEGINNING TILL THE END OF FOSCARNET MIN 16:18
FROM THE BEGINNING TILL THE END OF FOSCARNET MIN 16:18

...  1/3 of the patients have to stop because of adverse effects.  If the patient is in a life threatening situation and the viral load is really high we will start with Ganaciclovir even though it has these side effects  Low oral bioavailability and when it is given orally it looks like Acyclovir th ...
Drug Discovery and Development
Drug Discovery and Development

... to encourage pharmaceutical companies to develop drugs to treat diseases which affect fewer than 200,000 people in the US • Under this law, companies who develop such a drug are entitled to market it without competition for seven years. • This is considered a significant benefit, since the standards ...
SOCIAL PHARMACOLOGY - Keluarga IKMA FKMUA 2010 | …
SOCIAL PHARMACOLOGY - Keluarga IKMA FKMUA 2010 | …

... . Its consequenses for society, the goverment health authorities, health care services and drug manufactures ...
Pharmacology Exam for Grade 2008 Pakistan Students
Pharmacology Exam for Grade 2008 Pakistan Students

... Part Ⅰ Single Choice Questions (50 points) 1. The drugs that can pass across the blood brain barrier are A. small in molecular weight and ionized drugs B. small in molecular weight and nonionized drugs C. large in molecular weight and ionized drugs D. large in molecular weight and nonionized drugs E ...
Medication Use in the Elderly
Medication Use in the Elderly

... of drug therapy in the elderly and must individualize therapy as much as feasible ...
Drugs that increase the INR and risk of bleed Drugs that decrease
Drugs that increase the INR and risk of bleed Drugs that decrease

... The drugs in this list are more usually associated with loss of INR control in patients already established on warfarin. This list is not exhaustive - refer to the British National Formulary (BNF) for further information. If any of the drugs below are to be started in these patients then the use of ...
Network pharmacology - Center for Cancer Systems Biology
Network pharmacology - Center for Cancer Systems Biology

... instances exquisitely selective compounds may exhibit a lower-than-desired efficacy for the treatment of disease. Thus, compounds that selectively act on two or more targets of interest in theory should be more efficacious than single-target agents. Yıldırım et al. applied network analysis to drugs ...
Presentation
Presentation

... Medicines and Public health in EU • Future of the European system for evaluations and supervision of medicinal products • Relevance of the added therapeutic value of medicinal products ( registration criteria ? Placebo or comparator?) • Aspects determining innovation and research • Rational use of ...
Drugs and Toxicology
Drugs and Toxicology

... Schedule I—high potential for abuse; no currently accepted medical use in the U.S.; a lack of accepted safety for use under medical supervision Examples: heroin (diacetylmorphine), LSD, marijuana, ecstasy (MDMA) Schedule II—high potential for abuse; a currently accepted medical use with severe restr ...
Are You Drug Smart? - Do It Now Foundation
Are You Drug Smart? - Do It Now Foundation

... needles), alcohol, cocaine, and other drugs can lead to high-risk sex, which can increase risk of infection. ...
Lec-9 (1)
Lec-9 (1)

... one set of conditions but becomes unstable and spontaneously degrades under another set of conditions. • The advantage of a self-destruct drug is that inactivation does not depend on the activity of metabolic enzyme, which could vary from patient to patient. • e.g. Atracurium (neuromuscular blocking ...
factors modifying drug dose-response relationship
factors modifying drug dose-response relationship

... ● Increased body fat- reduces plasma levels of lipid soluble drugs ● Decreased total body water- increases concentration of water soluble drugs and intensity of response ● Reduced concentration of serum albuminmalnourishment decreases albumin and results in increased drug levels ...
Using the BNF
Using the BNF

... May inhibit lactation May inhibit infant’s sucking reflex ...
“What You Need To Know About Prescription Drugs in York County!”
“What You Need To Know About Prescription Drugs in York County!”

... • It is estimated that 40 percent of prescription drugs - particularly pain-killers, antibiotics, and cardiovascular medicine - that are prescribed outside of hospitals go unused every year. Left in the home, they present a serious health and safety hazard. Flushed down the drain, they contaminate o ...
8-21-2016 PPT
8-21-2016 PPT

... Bound drug does not have action ...
506861726d2032303038
506861726d2032303038

... • Pure Food and Drug Act -Standards for US marketing • Federal Food, Drug, and Cosmetic Act -Regulations -FDA approval • Controlled Substances Act -Established DEA -Schedule of Controlled Substances: C-I - Marijuana C-IV – Phenobarbital (treat seizures) C-II - Cocaine C-V – antidiarrheal (low abuse ...
ISTRUZIONI PER PREPARARE POSTER DA ESPORRE A …
ISTRUZIONI PER PREPARARE POSTER DA ESPORRE A …

... Assessment of the benefit-risk profile of drugs for non-responders to standard treatments. NB: this research topic is aimed at subgroups of patients who do not respond to standard therapies (e.g., because of the genetic modification of drug metabolism or targeting), and for whom a rationale for subs ...
Antitubercular Drugs
Antitubercular Drugs

...  Because of need for i.m. injections and lower margin of safety (ototoxicity and nephrotoxicity) Streptomycin is used only as an alternative to or in addition to other 1st line anti- TB drugs.  Use is restricted to a maximum of 2 months.  It is thus also labelled as a ‘supplemental’ 1st line drug ...
Snímek 1
Snímek 1

... Ultrarapid metabolizers may break down some drugs (e.g. some antidepressants) so quickly that the drug does not need to help at usual doses. They may also need a lower dose of a drug, in the case where a drug is metabolized in active metabolites (e.g. in some opioid analgesics) Poor metabolizers hav ...
Snímek 1
Snímek 1

... Ultrarapid metabolizers may break down some drugs (e.g. some antidepressants) so quickly that the drug does not need to help at usual doses. They may also need a lower dose of a drug, in the case where a drug is metabolized in active metabolites (e.g. in some opioid analgesics) Poor metabolizers hav ...
< 1 ... 133 134 135 136 137 138 139 140 141 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report